BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Resch B, Gusenleitner W, Müller W. The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years. Infection. 2002;30:193-197. [PMID: 12236559 DOI: 10.1007/s15010-002-2122-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Richard N, Komurian-Pradel F, Javouhey E, Perret M, Rajoharison A, Bagnaud A, Billaud G, Vernet G, Lina B, Floret D, Paranhos-Baccalà G. The impact of dual viral infection in infants admitted to a pediatric intensive care unit associated with severe bronchiolitis. Pediatr Infect Dis J 2008;27:213-7. [PMID: 18277932 DOI: 10.1097/INF.0b013e31815b4935] [Cited by in Crossref: 158] [Cited by in F6Publishing: 109] [Article Influence: 11.3] [Reference Citation Analysis]
2 Khuri-Bulos N, Lawrence L, Piya B, Wang L, Fonnesbeck C, Faouri S, Shehabi A, Vermund SH, Williams JV, Halasa NB. Severe outcomes associated with respiratory viruses in newborns and infants: a prospective viral surveillance study in Jordan. BMJ Open 2018;8:e021898. [PMID: 29780032 DOI: 10.1136/bmjopen-2018-021898] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
3 Kotaniemi-syrjänen A, Laatikainen A, Waris M, Reijonen TM, Vainionpää R, Korppi M. Respiratory syncytial virus infection in children hospitalized for wheezing: Virus-specific studies from infancy to preschool years. Acta Paediatrica 2005;94:159-65. [DOI: 10.1080/08035250410025069] [Cited by in Crossref: 36] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
4 Kotaniemi-Syrjänen A, Laatikainen A, Waris M, Reijonen TM, Vainionpää R, Korppi M. Respiratory syncytial virus infection in children hospitalized for wheezing: virus-specific studies from infancy to preschool years. Acta Paediatr 2005;94:159-65. [PMID: 15981748 DOI: 10.1111/j.1651-2227.2005.tb01884.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 0.2] [Reference Citation Analysis]
5 Mentel R, Ilgert U, Wegner U, Zimmermann K, Bruns R, G�rtler L. Molecular and clinical characteristics of respiratory syncytial virus infections in hospitalized children. Med Microbiol Immunol 2005;194:67-71. [DOI: 10.1007/s00430-003-0215-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
6 Castelli JB, Maeda WT, Aiello VD. Respiratory syncytial virus as a trigger of a pulmonary hypertensive crisis after operative correction of aortic coarctation. Cardiol Young 2007;17:223-5. [DOI: 10.1017/s1047951107000327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Straňák Z, Saliba E, Kosma P, Posfay-Barbe K, Yunis K, Farstad T, Unnebrink K, van Wyk J, Wegzyn C, Notario G, Kalus S, Campbell FJ. Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI). PLoS One 2016;11:e0157446. [PMID: 27310438 DOI: 10.1371/journal.pone.0157446] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
8 Vu LD, Siefker D, Jones TL, You D, Taylor R, DeVincenzo J, Cormier SA. Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis. Am J Respir Crit Care Med 2019;200:1414-23. [PMID: 31237777 DOI: 10.1164/rccm.201812-2366OC] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 11.5] [Reference Citation Analysis]
9 Resch B, Resch E, Müller W. Should respiratory care in preterm infants include prophylaxis against respiratory syncytial virus infection? The case in favour. Paediatr Respir Rev 2013;14:130-6. [PMID: 23375547 DOI: 10.1016/j.prrv.2012.12.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
10 Fischer Langley G, McCracken J, Arvelo W, Estevez A, Villarruel G, Prill M, Iwane M, Gray J, Moscoso F, Reyes L, Moir JC, Ortiz J, Lindblade K. The epidemiology and clinical characteristics of young children hospitalized with respiratory syncytial virus infections in Guatemala (2007-2010). Pediatr Infect Dis J 2013;32:629-35. [PMID: 23380666 DOI: 10.1097/INF.0b013e318289e3bc] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
11 Resch B. Palivizumab for the prophylaxis of respiratory syncytial virus infection. Pediatric Health 2008;2:265-78. [DOI: 10.2217/17455111.2.3.265] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Resch B, Eibisberger M, Morris N, Müller W. Respiratory syncytial virus- and influenza virus-associated hospitalizations in infants less than 12 months of age. Pediatr Infect Dis J 2011;30:797-9. [PMID: 21386747 DOI: 10.1097/INF.0b013e318215cf3e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
13 Resch B, Gusenleitner W, Nuijten MJ, Lebmeier M, Wittenberg W. Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria. Clin Ther. 2008;30:749-760. [PMID: 18498923 DOI: 10.1016/j.clinthera.2008.03.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
14 Resch B, Kurath-Koller S, Eibisberger M, Zenz W. Prematurity and the burden of influenza and respiratory syncytial virus disease. World J Pediatr 2016;12:8-18. [PMID: 26582294 DOI: 10.1007/s12519-015-0055-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
15 Kwinta P, Lis G, Klimek M, Grudzien A, Tomasik T, Poplawska K, Pietrzyk JJ. The prevalence and risk factors of allergic and respiratory symptoms in a regional cohort of extremely low birth weight children (<1000 g). Ital J Pediatr 2013;39:4. [PMID: 23332103 DOI: 10.1186/1824-7288-39-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
16 Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simões EA, Rudan I, Weber MW, Campbell H. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545-55. [PMID: 20399493 DOI: 10.1016/S0140-6736(10)60206-1] [Cited by in Crossref: 1677] [Cited by in F6Publishing: 1063] [Article Influence: 139.8] [Reference Citation Analysis]
17 Bont L, Checchia PA, Fauroux B, Figueras-Aloy J, Manzoni P, Paes B, Simões EA, Carbonell-Estrany X. Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries. Infect Dis Ther 2016;5:271-98. [PMID: 27480325 DOI: 10.1007/s40121-016-0123-0] [Cited by in Crossref: 119] [Cited by in F6Publishing: 109] [Article Influence: 19.8] [Reference Citation Analysis]
18 Park BK, Kim D, Wu G, Choi SH, Kim D, Lee Y, Kwon H. Effect of epitope-CpG-DNA-liposome complex without carriers on vaccination of respiratory syncytial virus infection. J Korean Soc Appl Biol Chem 2014;57:667-76. [DOI: 10.1007/s13765-014-4215-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
19 Borchers AT, Chang C, Gershwin ME, Gershwin LJ. Respiratory syncytial virus--a comprehensive review. Clin Rev Allergy Immunol 2013;45:331-79. [PMID: 23575961 DOI: 10.1007/s12016-013-8368-9] [Cited by in Crossref: 216] [Cited by in F6Publishing: 202] [Article Influence: 27.0] [Reference Citation Analysis]
20 Österreichische Gesellschaft für Kinder- und Jugendheilkunde (ÖGKJ). Konsensuspapier zur Prophylaxe der RSV-Infektion mit Palivizumab und Post-RSV-Atemwegserkrankung. Monatsschr Kinderheilkd 2008;156:381-3. [DOI: 10.1007/s00112-008-1722-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
21 Resch B. Burden of respiratory syncytial virus infection in young children. World J Clin Pediatr 2012; 1(3): 8-12 [PMID: 25254161 DOI: 10.5409/wjcp.v1.i3.8] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
22 Abraha HY, Lanctôt KL, Paes B. Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention. Expert Rev Respir Med 2015;9:779-99. [PMID: 26457970 DOI: 10.1586/17476348.2015.1098536] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
23 Ruef C. Respiratory Syncytial Virus Infections — An Underdiagnosed Entity? Infection 2002;30:185-185. [DOI: 10.1007/s15010-002-7402-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Resch B, Puchas C, Urlesberger B. Respiratory syncytial virus-associated hospitalization rates in high-risk populations: an observational comparative cohort analysis. Eur J Clin Microbiol Infect Dis 2018;37:2413-4. [DOI: 10.1007/s10096-018-3388-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Resch B. Palivizumab in preventing respiratory syncytial virus-related hospitalization in high-risk infants. Expert Rev Pharmacoecon Outcomes Res 2008;8:529-38. [PMID: 20528363 DOI: 10.1586/14737167.8.6.529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
26 Maksić H, Heljić S, Skokić F, Šumanović-Glamuzina D, Milošević V, Zlatanović A, Gerard N. Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina. Bosn J Basic Med Sci 2018;18:279-88. [PMID: 29750895 DOI: 10.17305/bjbms.2018.2318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
27 Butt ML, Symington A, Janes M, Elliott L, Steele S, Paes BA. The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study. Eur J Pediatr 2011;170:907-13. [PMID: 21174120 DOI: 10.1007/s00431-010-1376-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
28 Fodha I, Landolsi N, Vabret A, Sboui H, Trabelsi A, Freymuth F. Epidemiology and clinical presentation of respiratory syncytial virus infection in a Tunisian neonatal unit from 2000 to 2002. Ann Trop Paediatr 2004;24:219-25. [PMID: 15479571 DOI: 10.1179/027249304225018966] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
29 Resch B, Kurath S, Manzoni P. Epidemiology of respiratory syncytial virus infection in preterm infants. Open Microbiol J 2011;5:135-43. [PMID: 22262986 DOI: 10.2174/1874285801105010135] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
30 Frange P, Toubiana J, Parize P, Moulin F, Scemla A, Leruez-Ville M. Preventing respiratory syncytial virus infections in hospitalized children and adults: should we do better? Infect Prev Pract 2020;2:100041. [PMID: 34316555 DOI: 10.1016/j.infpip.2020.100041] [Reference Citation Analysis]
31 Chaw PS, Wong SWL, Cunningham S, Campbell H, Mikolajczyk R, Nair H; RESCEU Investigators. Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis. J Infect Dis 2020;222:S613-9. [PMID: 31599958 DOI: 10.1093/infdis/jiz150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
32 Falkenstein-Hagander K, Månsson AS, Redmo J, Nilsson Wimar P, Widell A. Viral aetiology and clinical outcomes in hospitalised infants presenting with respiratory distress. Acta Paediatr 2014;103:625-9. [PMID: 24606114 DOI: 10.1111/apa.12623] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
33 Paranhos-Baccalà G, Komurian-Pradel F, Richard N, Vernet G, Lina B, Floret D. Mixed respiratory virus infections. J Clin Virol 2008;43:407-10. [PMID: 18829380 DOI: 10.1016/j.jcv.2008.08.010] [Cited by in Crossref: 79] [Cited by in F6Publishing: 77] [Article Influence: 5.6] [Reference Citation Analysis]
34 Resch B, Gusenleitner W, Mueller WD. Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection. Acta Paediatr 2007;96:495-8. [PMID: 17326757 DOI: 10.1111/j.1651-2227.2007.00226.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.2] [Reference Citation Analysis]
35 Van de Steen O, Miri F, Gunjaca M, Klepac V, Gross B, Notario G, Wegzyn CM. The Burden of Severe Respiratory Syncytial Virus Disease Among Children Younger than 1 Year in Central and Eastern Europe. Infect Dis Ther 2016;5:125-37. [PMID: 27174177 DOI: 10.1007/s40121-016-0109-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
36 Sommer C, Resch B, Simões EA. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J 2011;5:144-54. [PMID: 22262987 DOI: 10.2174/1874285801105010144] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 9.9] [Reference Citation Analysis]
37 Resch B, Paes B. Are late preterm infants as susceptible to RSV infection as full term infants? Early Hum Dev 2011;87 Suppl 1:S47-9. [PMID: 21276672 DOI: 10.1016/j.earlhumdev.2011.01.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
38 Resch B, Pasnocht A, Gusenleitner W, Müller W. Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age. J Infect 2005;50:397-403. [PMID: 15907547 DOI: 10.1016/j.jinf.2004.06.015] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 3.1] [Reference Citation Analysis]
39 Aldous WK, Gerber K, Taggart EW, Thomas J, Tidwell D, Daly JA. A comparison of Binax NOW to viral culture and direct fluorescent assay testing for respiratory syncytial virus. Diagn Microbiol Infect Dis 2004;49:265-8. [PMID: 15313531 DOI: 10.1016/j.diagmicrobio.2004.04.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
40 Somech R, Tal G, Gilad E, Mandelberg A, Tal A, Dalal I. Epidemiologic, socioeconomic, and clinical factors associated with severity of respiratory syncytial virus infection in previously healthy infants. Clin Pediatr (Phila) 2006;45:621-7. [PMID: 16928839 DOI: 10.1177/0009922806291012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
41 Rödl S, Resch B, Hofer N, Marschitz I, Madler G, Eber E, Zobel G. Prospective evaluation of clinical scoring systems in infants with bronchiolitis admitted to the intensive care unit. Eur J Clin Microbiol Infect Dis 2012;31:2667-72. [PMID: 22526870 DOI: 10.1007/s10096-012-1612-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]